Download in electronic PDF format for $25

Kalchem International - Chemicals and Compounding Supplies

Search the Complete Journal Archives

Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome

Author(s):  Riepl Mike

Issue:  Nov/Dec 2018 - Volume 22, Number 6
View All Articles in Issue

Abstract:  Homeostasis of the human vaginal microbiome, which consists of the bacteriome (colonizing bacteria) and the mycobiome (resident fungi), is essential to the health of the female reproductive system. Dysbiosis of either microbial community can be caused by a variety of factors ranging from behavioral issues (personal-hygiene practices, the choice of contraceptives, smoking, etc.) to biological variables (the host-microbiome composition, menstruation, the robustness of the host’s immune response). Clinicians often consult compounding pharmacistsbabout the formulation and use of customized preparations to treat vaginal diseases and re-establish a healthful vaginal microenvironment when commercially manufactured products have failed or are unavailable. In this article, the function of the human vaginal bacteriome and mycobiome are examined, a common microorganism identified in each of those microenvironments is discussed, factors that cause dysbiosis are reviewed, and the role of biofilm in the vaginal microbiota is explored. A question typical of those asked by prescribers committed to improving women’s health and decreasing the incidence of recurring bacterial vaginosis or fungal infections is answered. Formulations for compounds that help ensure or reestablish the homeostasis of the human vaginal bacteriome and mycobiome are also provided.

Related Keywords: Mike Riepl, RPh, colonizing bacteria, mycobiome, resident fungi, female reproductive system, dysbiosis, vagina, vaginal microenvironment, vaginal microbiota, vaginal bacteriome, Lactobacillus species, Candida species, candidiasis, C albicans, vaginal mucobiome, biofilms, fungi, fungus, vaginal suppository, lactobacilli, vaginal health, menopause, boric acid vaginal suppositories, estriol vaginal cream, formulations, Lactobacillus acidophilus, women, bacterial vaginosis, fungus infection, fungal infection

Related Categories: FORMULATIONS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome Riepl Mike Nov/Dec 2018 456-465 Buy
Gentian Violet Vaginal Suppositories Allen Loyd V Jr Nov/Dec 2009 556 Buy
Estradiol 0.1% Vaginal Solution Allen Loyd V Jr Sep/Oct 2008 450 Buy
Mupirocin 1% (20-mg) Vaginal Suppository Allen Loyd V Jr Jul/Aug 2009 338 Buy
Nystatin 100,000-units Vaginal Inserts Allen Loyd V Jr Jul/Aug 2016 322 Buy
Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications Agbi Kelechi E, Hover Sara, Carvalho Maria May/Jun 2018 196-202 Buy
Clindamycin 100-mg Vaginal Suppositories Allen Loyd V Jr Jul/Aug 2009 334 Buy
Clotrimazole 500-mg Vaginal Suppositories Allen Loyd V Jr Nov/Dec 2003 469 Buy
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel Nov/Dec 2018 504-511 Buy
Boric Acid 600-mg Vaginal Suppository Allen Loyd V Jr Jan/Feb 2004 52 Buy